Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
---|
07/17/2003 | WO2002099124A3 Characterising polypeptides |
07/17/2003 | US20030135063 Especially Type II diabetes; stimulating the kinase activity of the insulin receptor; activating the insulin receptor |
07/17/2003 | US20030135057 5-amino- and 5-thio- substituted; prepared from a methylenedithietane intermediate |
07/17/2003 | US20030135053 For use in human or veterinary conditions, that may be dermatological, rheumatic, respiratory, or cardiovascular and may be used in cosmetics |
07/17/2003 | US20030135046 Synthesis of heteroarylamine intermediate compounds |
07/17/2003 | US20030135045 Glycoprotein IIb/IIIa antagonists |
07/17/2003 | US20030134880 Novel cd23 inhibitors |
07/17/2003 | US20030134878 Use of a compound in providing refreshedness on waking and a method for the treatment of drowsiness therewith |
07/17/2003 | US20030134874 Multicyclic compounds which inhibit leukocyte adhesion mediated by VLA-4 |
07/17/2003 | US20030134859 Substituted 2-chloro-5-nitrobenzamides; treating retrograde osteoporosis and diabetes mellitus |
07/17/2003 | US20030134857 Synergistic insecticide mixtures |
07/17/2003 | US20030134848 Substituted 1-aza-2-imino-heterocycles and their use as nicotinic acetylcholin receptors activators |
07/17/2003 | US20030134836 Substituted arylamine derivatives and methods of use |
07/17/2003 | US20030133992 Method and composition for preventing or reducing the symptoms of insulin resistance syndrome |
07/17/2003 | US20030131422 Primary intermediates for oxidative coloration of hair |
07/17/2003 | CA2471752A1 Carboxamidine derivatives and their use in the treatment of vascular diseases |
07/16/2003 | EP1327630A1 New derivatives of cyano-aryl (or cyanoheteroaryl)-carbonyl-piperazinyl-pyrimidines, their preparation and application as medication |
07/16/2003 | EP1327628A2 Lipidization of hydrophilic molecules |
07/16/2003 | EP1326993A2 PRODUCTION OF g(a)-HYDROXY-CARBOXYLIC ACIDS USING A COUPLED ENZYME SYSTEM |
07/16/2003 | EP1326858A2 Piperidine compounds as anti-allergic |
07/16/2003 | EP1326856A1 Pyridine derivatives with ikb-kinase (ikk-beta) inhibiting activity |
07/16/2003 | EP1326840A2 Substituted heterocyclic compounds for treating multidrug resistance |
07/16/2003 | EP1326838A1 Novel crystalline forms of a factor xa inhibitor |
07/16/2003 | EP1326837A1 Crystal forms of 1- 6-chloro-5-(trifluoromethyl)-2-pyridinyl]piperazine.hydrochloride |
07/16/2003 | EP1326836A1 Process for making 3-amino-2-chloro-4-methylpyridine |
07/16/2003 | EP1326835A1 Benzamide compounds as apo b secretion inhibitors |
07/16/2003 | EP1326834A2 2-substituted heterocyclic compounds |
07/16/2003 | EP1326833A2 Substituted heterocyclic compounds for treating multidrug resistance |
07/16/2003 | EP1326827A2 Insecticidal 1,8-naphthalenedicarboxamides |
07/16/2003 | EP1284733A4 Novel processes for preparing torsemide intermediate |
07/16/2003 | EP1175416B1 Heteroaryl diazacycloalkanes, their preparation and use |
07/16/2003 | EP1155000B1 2-aminopyridines containing fused ring substituents |
07/16/2003 | CN1430608A Substituted iminoazines |
07/16/2003 | CN1430607A Benzophenones as inhibitors of IL-1 beta and TNF-alpha |
07/16/2003 | CN1430606A New process |
07/16/2003 | CN1430602A Ary-and heteroaryl sulfonates compounds |
07/16/2003 | CN1430596A New gamma selective retinoids |
07/16/2003 | CN1114608C Novel camptothecine analogues, prepn. method therefor, use thereof, and pharmaceutical compositions contg. same |
07/16/2003 | CN1114598C Aromatic compounds and pharmaceutical compositions containing them |
07/16/2003 | CN1114596C Biphenyl derivatives |
07/16/2003 | CN1114595C Process for preparing pyridyl methyl ester isothiocy anide |
07/16/2003 | CN1114594C D4 receptor selectivity piperazine derivatives |
07/16/2003 | CN1114593C Preparation of 2-substituted pyridines |
07/16/2003 | CN1114591C Cyclic amide compounds |
07/15/2003 | US6593493 2-(Carboxy(unsaturated)alkyl)-1-(haloalkoxy)benzene derivatives; retinoid X receptors; cardiovascular, skin, eating and vision disorders; anticarcinogenic agents; non-insulin-dependent diabetes |
07/15/2003 | US6593486 Reacting halobenzoic acid with 2,2,2-trifluoroethanol; thenhaloacetonitrile |
07/15/2003 | US6593475 Preparation of derivative of 3-sulfonamido-4-phenylaminopyridine |
07/15/2003 | US6593472 NK-1 receptor active amine oxide prodrugs |
07/15/2003 | US6593471 Synthesis of heteroarylamine intermediate compounds |
07/15/2003 | US6593438 Catalyst composition and method of polymerization |
07/15/2003 | US6593352 2-phenylalkylaminobenzoic acid containing substituted benzylsufamoyl group; useful for treating cardiovascular disorders, and for preserving or storing a transplant for surgery |
07/15/2003 | US6593330 Compounds and their use |
07/15/2003 | US6593327 Compounds and compositions as protease inhibitors |
07/15/2003 | US6592633 Less selective colorations and which are particularly resistant to the various attacking factors to which the hair may be subjected |
07/15/2003 | CA2238465C Triaromatic compounds, compositions containing them and uses |
07/15/2003 | CA2218766C Bicyclic-aromatic compounds |
07/15/2003 | CA2056191C Herbicidal carboxamide derivatives |
07/10/2003 | WO2003055874A1 Bipyridinyl derivatives as a highly selective cyclooxygenase-2 inhibitor |
07/10/2003 | WO2003055861A1 Benzocyclodecane derivatives with antitumor activity |
07/10/2003 | WO2003055851A1 Hydroxamic acid derivative and mmp inhibitor containing the same as active ingredient |
07/10/2003 | WO2003055850A1 β-AMYLOID PROTEIN PRODUCTION/SECRETION INHIBITORS |
07/10/2003 | WO2003055848A2 Urea derivatives as vr1- antagonists |
07/10/2003 | WO2003055843A1 Agaricoglycerides and analogs |
07/10/2003 | WO2003055482A1 Amide derivatives as gk activators |
07/10/2003 | WO2001098248A3 Hiv integrase inhibitors |
07/10/2003 | US20030130521 Enantioselective reduction to produce an optically active hydroxyethylpyridine derivative; further derivatized to an intermediate such as a dihydroxyethylpyridine derivative; use of microorganism derived carbonyl-reducing enzymes |
07/10/2003 | US20030130520 Producing substituted 2-nitro-guanidine derivatives. |
07/10/2003 | US20030130515 Aryl or heteroaryl substituted 3,4-dihydroanthracene and aryl or heteroaryl substituted benzo[1,2-g]-chrom-3-ene, benzo[1,2-g]-thiochrom-3-ene and benzo [1,2-g]-1,2-dihydroquinoline derivatives having retinoid antagonist or retinoid inverse agonist type biological activity |
07/10/2003 | US20030130511 Replacing a halogen atom with an electrophilic group (e.g., a formyl group) using either a mixture of an organomagnesium halide and an alkyllithium or a reaction product of the two, such as trialkylmagnesium lithium |
07/10/2003 | US20030130508 3,5-bis(trifluoromethyl)phenylmethylene-substituted derivatives of nicotamide or pyridinylaminocarbonyl compounds; used to treat disorders of the central nervous system such as anxiety, depression and psychosis. |
07/10/2003 | US20030130349 Inhibitors of alpha 4beta1 mediated cell adhesion |
07/10/2003 | US20030130345 C2-substituted idan-1-ones and their derivatives, processes for their preparation and their use as pharmaceuticals |
07/10/2003 | US20030130342 Such as anticoagulant 3-(6-(4-(aminoiminomethyl)phenyl methoxy)-2-methyl-2H-1-benzopyran-2-yl)propanoic acid hydrochloride |
07/10/2003 | US20030130339 Such as (E)-2-pyridineethenyl-4-fluorobenzyl sulfone; antitumor/anticancer agents |
07/10/2003 | US20030130296 FXR NR1H4 nuclear receptor binding compounds |
07/10/2003 | US20030130295 Substituted 2-aminoacetamides and the use thereof |
07/10/2003 | US20030130289 Inhibitors of glycogen synthase kinase 3 |
07/10/2003 | US20030130287 Psychological disorders; central nervous system disorders; antidepressants; Parkinson's disease; Alzheimer's disease;cardiovascular disorders |
07/10/2003 | US20030130232 Amidine derivatives, the preparation and use thereof as medicaments with LTB4 antagonistic effect |
07/10/2003 | US20030129670 Using hydrophobic fluorescent ion capable of redistributing from a first face of the membrane to a second face of the membrane in response to changes in the membrane potential |
07/10/2003 | US20030129552 Color photothermography |
07/10/2003 | US20030127129 Charge transfer material, and photoelectric conversion device and photoelectric cell using same, and pyridine compound |
07/10/2003 | CA2471910A1 Benzocyclodecane derivatives with antitumor activity |
07/10/2003 | CA2471049A1 Amide derivatives as gk activators |
07/10/2003 | CA2469967A1 Urea derivatives as vr1- antagonists |
07/09/2003 | EP1325925A1 Chromium catalysts active in olefin polymerization |
07/09/2003 | EP1325912A1 2,2-diphenylbutanamide derivatives and medicines containing the same |
07/09/2003 | EP1325908A1 Process for the preparation of an enantiomerically enriched thio compound |
07/09/2003 | EP1325903A1 2,3-diphenylpropionic acid derivatives or their salts, medicines or cell adhesion inhibitors containing the same, and their usage |
07/09/2003 | EP1325671A1 Organometallic compounds and emission-shifting organic electrophosphorescence |
07/09/2003 | EP1324996A2 Substituted aryl ketones |
07/09/2003 | EP1324986A1 Nitrogen-containing compounds and their use as glycine transport inhibitors |
07/09/2003 | EP1324981A2 Aminopyridinyl-, aminoguanidinyl- and alkoxyguanidinyl- substituted phenyl acetamides as protease inhibitors |
07/09/2003 | EP1165496B1 Substituted aniline compounds |
07/09/2003 | EP1066251B1 Method for the production of 1,3-disubstituted 2-nitroguanidines |
07/09/2003 | CN1429225A C10 carbonate substituted taxanes as antitumor agents |
07/09/2003 | CN1429210A Substituted thioacetamides |
07/09/2003 | CN1429200A Anthranyl amides and their use as medicaments |
07/09/2003 | CN1429199A Insecticidal 1,8-naphthalenedicarboxamides |
07/09/2003 | CN1429198A Novel phenyl-proparylether derivatives |